BSE filing, NSE: NAVINFLUOR. Summary written from the filing by ALFA Finder's alert engine.
Navin Fluorine International Ltd: key numbers
- Share price
- ₹8,501.00
- Market cap
- ₹43,614 Cr
- Revenue (annual)
- ₹3,314 Cr
- Net profit (annual)
- ₹663.5 Cr
- P/E (TTM)
- 55.2×Sector 34.1×
- Promoter holding
- 27.08%+0.00% QoQ
- FII holding
- 23.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Navin Fluorine International Ltd
All →Navin Fluorine International Order Update: ₹1,710 Cr
Navin Fluorine's subsidiary NFASL amended its $410M Honeywell/Solstice HFO contract, extending tenure to December 2032. Additional revenue potential is about $180M, taking total contract value to about $590M.
- Value
- ₹1,710 Cr
- From
- Solstice Advanced Materials US, Inc. (assignee of Honeywell International Inc.)
- Execution
- Extended to December 2032 (total 11 years)
Navin Fluorine International Employee Stock Options
Navin Fluorine allotted 23,500 equity shares to employees on exercise of options under its ESOP Scheme 2017. No cash consideration or transaction value is stated in the filing.
Navin Fluorine International Other Announcement
Navin Fluorine International Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with Regulation 31(1)(b) of the Listing Regulations.
Navin Fluorine International Production Started
Navin Fluorine's subsidiary, NFASL, has commenced commercial production at its debottlenecked Multi-Purpose Plant at the Dahej site. No new financial value is reported in this update.
Navin Fluorine International Production Started
Navin Fluorine's subsidiary NFASL has commissioned debottlenecking capacity at its Dahej Multi-Purpose Plant. Commercial production and product dispatch commenced today following a ₹75 Crore investment.
- Value
- ₹75.00 Cr
Navin Fluorine International Board Meeting Date
Navin Fluorine International Limited has scheduled a board meeting for October 30, 2026. The board will consider Q2 FY27 financial results and an interim dividend.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.